AWA Point
Tag: IPR protection
What patent protection does Gilead’s COVID-19 treatment Remdesivir have?
On 29 April 2020 Gilead announced that its drug Remdesivir has a positive effect in the treatment of COVID-19
Enforcement in the East II – Why should I patent in Russia?
This is a second blog post on patent enforcement in Eastern countries. Having already discussed China, we now turn